Showing results (221-230 of 232) with videos related to
Sort By:
Pageof 24
Neurology|May 5, 1998
Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomographyA Kishore, T G Nygaard, R de la Fuente-Fernandez, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 1999
Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjectsG L Chan, J E Holden, A J Stoessl, et al.Neurology|November 27, 2002
SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findingsS Furtado, M Farrer, Y Tsuboi, et al.Synapse (New York, N.Y.)|August 15, 1998
Age-dependent decline of dopamine D1 receptors in human brain: a PET studyY Wang, G L Chan, J E Holden, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 16, 2000
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuationsR de la Fuente-Fernández, P K Pal, F J Vingerhoets, et al.Progress in Brain Research|January 1, 1990
Treatment of refractory Parkinson's disease with adrenal medullary autografts utilizing two-stage surgeryK C Petruk, A F Wilson, D R Schindel, et al.Annals of Neurology|April 13, 2000
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's diseaseC S Lee, A Samii, V Sossi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 1998
Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjectsG L Chan, J E Holden, A J Stoessl, et al.Neurology|May 12, 2004
Autosomal dominant parkinsonism associated with variable synuclein and tau pathologyZ K Wszolek, R F Pfeiffer, Y Tsuboi, et al.Neurology|December 15, 2004
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease)J R M Oliveira, E Spiteri, M J Sobrido, et al.Pageof 24